alpha-acetoxy-N-nitrosomorpholine,
N-nitrosomorpholine,
N-NITROSOMORPHOLINE,
4-Nitrosomorpholine,
59-89-2,
Nitrosomorpholine,
Morpholine, 4-nitroso-,
N-Nitrosomorpholin,
NMOR,
Morpholine, N-nitroso-,
N-Nitrosomorfolin,
NSC 139,
N-Nitrosomorfolin [Czech],
N-Nitrosomorpholin [German],
UNII-3L25FO7FN7,
CCRIS 473,
4-Nitroso-morpholine,
HSDB 4308,
NCI-C02164,
BRN 0112139,
3L25FO7FN7,
CHEBI:76326,
DSSTox_CID_1056,
DSSTox_RID_75922,
DSSTox_GSID_21056,
CAS-59-89-2,
Molsidomine impurity B,
ACMC-209mgu,
AC1L1LOO,
AC1Q6R9U,
WLN: T6N DOTJ ANO,
N-Nitrosomorpholine (NMOR),
CHEMBL165908,
NSC139,
SCHEMBL1578515,
DTXSID4021056,
CTK1H1015,
NSC-139,
ZKXDGKXYMTYWTB-UHFFFAOYSA-N,
KS-000013MA,
ZINC3875397,
Tox21_202132,
Tox21_302867,
ANW-33388,
LS-254,
MFCD00039710,
STL301087,
AKOS015903272,
FCH1116583,
MCULE-8445460226,
NCGC00249174-01,
NCGC00256343-01,
NCGC00259681-01,
DB-053489,
TC-122133,
FT-0631266,
N0466,
N-Nitrosomorpholine 10 microg/mL in Methanol,
C19283,
C-51142,
I14-19297,
Molsidomine impurity B, European Pharmacopoeia (EP) Reference Standard,
1219805-76-1,
67587-56-8,
Morpholine,4-nitroso-,
C4H8N2O2,
alpha-acetoxy-N-nitrosomorpholine,
CID6046,
C4-H8-N2-O2,
AR-1G4139,
4-27-00-00627 (Beilstein Handbook Reference),
C002741,
68298-21-5,